Substance Use Disorders and Dual Diagnosis Management

Substance use disorders frequently coexist with mood, anxiety, and psychotic conditions, creating complex diagnostic and treatment challenges. Integrated care models that address both psychiatric and addiction components simultaneously are associated with improved outcomes. Advances in medication-assisted treatment, behavioral therapies, and relapse prevention strategies are enhancing recovery pathways. Neurobiological research is deepening understanding of addiction circuitry and vulnerability factors. Screening and early intervention programs reduce progression and long-term complications. Multidisciplinary collaboration between psychiatrists, addiction specialists, and social services strengthens comprehensive support systems. Addressing stigma and expanding access to evidence-based care remain critical for effective dual diagnosis management.

    Related Conference of Substance Use Disorders and Dual Diagnosis Management

    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    March 09-10, 2026

    7th Annual Congress on Psychiatry

    Singapore City, Singapore
    March 23-24, 2026

    4th World Congress on Psychiatry

    Tokyo, Japan
    April 13-14, 2026

    8th International Congress on Mental Health

    Tokyo, Japan
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France
    June 01-02, 2026

    11th International Conference on Addiction Therapy

    Zurich, Switzerland
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France

    Substance Use Disorders and Dual Diagnosis Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in